Niamh O'Flaherty

Dr. Niamh O'Flaherty


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
CSClive R. Seed
Clive R. Seed
JAJean‐Pierre Allain
Jean‐Pierre Allain
MLMiquel Lozano
Miquel Lozano
SLSyria Laperche
Syria Laperche
PGPierre Gallian
Pierre Gallian
MSMichael Schmidt
Michael Schmidt

25 November 2021 in Journal of Clinical Virology
Verified
Journal Article
Open access
DBDearbhla Butler
Dearbhla Butler
DCDermot Coyne
Dermot Coyne
LPLouise Pomeroy
Louise Pomeroy
PWPádraig Williams
Pádraig Williams
PHPaul Holder
Paul Holder
NONiamh O'Flaherty
Niamh O'Flaherty
Blood donor studies offer a unique opportunity to screen healthy populations for the presence of antibodies to emerging infections. We describe the use of blood donor specimens to track the ‘first-wave’ of the COVID-19 pandemic in Ireland. A random selection of donor samples received by the Irish Blood Transfusion Service (IBTS) between February and September 2020 (n = 8,509) were screened by multiple commercial SARs-CoV-2 antibody assays. The antibody detection rate was adjusted to the population to determine the SARS-CoV-2 seroprevalence in Ireland. SARS-CoV-2 antibody detection rose significantly during the first peak of COVID-19 infection, increasing from 0.3% in March, to 2.9% in April (p < 0.0001, The first SARS-CoV-2 antibody positive donor samples were collected on the 17th February 2020, 2 weeks prior to the first official notification. This is the earliest serological evidence of SARS-CoV-2 circulating in the Irish population. Our results also show a significantly higher antibody prevalence in the Capital city and in donors less than 40 years of age. The present study demonstrates evidence of SARS-CoV-2 antibody reactivity across all age groups and counties. The critical value of blood donor seroprevalence studies is apparent in this report which identified the earliest serological evidence of SARS-CoV-2 infection in Ireland, as well as documenting the evolution of COVID-19 pandemic in Ireland over time.

14 November 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
NONiamh O'Flaherty
Niamh O'Flaherty
LBLouise Bryce
Louise Bryce
JNJames Nolan
James Nolan
MLMark David Lambert
Mark David Lambert
Bacterial contamination of platelet components (PC) poses the greatest microbial risk to recipients, as bacteria can multiply over the course of PC storage at room temperature. Between 2010 and 2020, the Irish Blood Transfusion Service (IBTS) screened over 170,000 buffy coat-derived pooled (BCDP) and single-donor apheresis platelets (SDAPs) with the BACT/ALERT 3D microbial detection system (Biomerieux, L’Etoile, France), using a two-step screening protocol which incorporated primary and secondary cultures. Although the protocol was successful in averting septic transfusion reactions (STRs), testing large sample volumes at later time points was reported to improve detection of bacterial contamination. A modified large-volume delayed sampling (LVDS)-type protocol was adopted in 2020, which in the case of SDAP was applied to collections rather than individual splits (2020–2023, 44,642 PC screened). Rates of bacterial contamination for BCDP were 0.125% on Day-2, 0.043% on Day-4 vs. 0.191% in the post-LVDS period. SDAP contamination rates in the pre-LVDS period were 0.065% on Day-1, 0.017% on Day-4 vs. 0.072% in the post-LVDS period. Confirmed STRs were absent, and the interdiction rate for possibly contaminated SDAP was over 70%. In the post-LVDS period, BCDPs had a higher total positivity rate than SDAPs, 0.191% (1:525) versus 0.072% (1:1385), respectively, (chi-squared 12.124, 1 df, p = 0.0005). The majority of organisms detected were skin-flora-type, low pathogenicity organisms, including coagulase-negative staphylococci and Cutibacterium acnes, with little change in the frequency of clinically significant organisms identified over time. Both protocols prevented the issue of potentially harmful components contaminated (rarely) with a range of pathogenic bacteria, including Escherichia coli, Serratia marcesens, Staphylococcus aureus, and streptococci. Culture positivity of outdates post-LVDS whereby 100% of expired platelets are retested provides a residual risk estimate of 0.06% (95% CI 0.016–0.150). However, bacterial contamination rates in expired platelets did not demonstrate a statistically significant difference between the pre-LVDS 0.100% (CI 0.033–0.234) and post-LVDS 0.059% (0.016–0.150) periods (chi-squared = 0.651, 1 df, p = 0.42).

14 February 2018 in Vox Sanguinis
Verified
Journal Article
Open access
PDF file
NONiamh O'Flaherty
Niamh O'Flaherty
IUI. Ushiro‐Lumb
I. Ushiro‐Lumb
LPL. Pomeroy
L. Pomeroy
SIS. Ijaz
S. Ijaz
FBF. Boland
F. Boland
JOJ. O'RIordan
J. O'RIordan
Lookback was initiated upon notification of an acute HBV infection in a repeat Irish donor, 108 days post‐donation. The donation screened non‐reactive by individual‐donation nucleic acid testing (ID‐NAT) using the Procleix Ultrio Elite multiplex assay and again when the archived sample was retested, but the discriminatory assay for HBV was reactive. The immunocompromised recipient of the implicated red cell component was tested 110 days post‐transfusion, revealing a HBV DNA viral load of 470 IU/ml. Genotype C2 sequences identical across two regions of the HBV genome were found in samples from the donor and recipient.

16 May 2024 in Vox Sanguinis
Verified
Journal Article
Open access
MPMarcel Prax
Marcel Prax
CMCarl P. McDonald
Carl P. McDonald
IBIsabelle Bekeredjian‐Ding
Isabelle Bekeredjian‐Ding
MCMarc Cloutier
Marc Cloutier
UGUte Gravemann
Ute Gravemann
SPSubgroup On Bacteria The Isbt Transfusion‐Transmitted Infectious Diseases Working Party
Subgroup On Bacteria The Isbt Transfusion‐Transmitted Infectious Diseases Working Party
Background and Objectives: Blood safety measures used by blood establishments to increase blood component safety can be validated using Transfusion‐Relevant Bacterial Reference Strains (TRBRS). Ultra‐cold storage conditions and manual preparation of the current TRBRS may restrict their practical use. To address this issue, the ISBT Transfusion‐Transmitted Infectious Diseases Working Party's Bacterial Subgroup organized an international study to validate TRBRS in a user‐friendly, lyophilised format.Materials and Methods: Two bacterial strains Klebsiella pneumoniae PEI‐B‐P‐08 and Staphylococcus aureus PEI‐B‐P‐63 were manufactured as lyophilised material. The lyophilised bacteria were distributed to 11 different labs worldwide to assess the robustness for enumeration, identification and determination of growth kinetics in platelet concentrates (PCs).Results: Production of lyophilised TRBRS had no impact on the growth properties compared with the traditional format. The new format allows a direct low‐quantity spiking of approximately 30 bacteria in PCs for transfusion‐relevant experiments. In addition, the lyophilised bacteria exhibit long‐term stability across a broad temperature range and can even be directly rehydrated in PCs without losing viability. Interlaboratory comparative study demonstrated the robustness of the new format as 100% of spiked PC exhibited growth.Conclusion: Lyophilised TRBRS provide a user‐friendly material for transfusion‐related studies. TRBRS in the new format have improved features that may lead to a more frequent use in the quality control of transfusion‐related safety measures in the future.